As modification of tau and its accumulation at synapses strongly correlates with cognitive impairments in AD, the ability of leptin to limit tau phosphorylation and its targeting to synapses has important implications for the neuroprotective actions of leptin in CNS disorders like AD. The gene discussed is MAPT; the disease is Cognitive impairment.